Description
The Unique Offering of Rovamycine 3.000.000 iu Eczacibasi
Rovamycine 3.000.000 iu Eczacibasi stands out in the pharmaceutical market as a leading macrolide antibiotic. Its formulation, based on the active ingredient Spiramycin, offers robust antibacterial properties that are essential for treating various bacterial infections. This product is manufactured by Eczacıbaşı, a reputable name known for high-quality pharmaceuticals, which adds considerable credibility and trust to Rovamycine. With a competitive price point of 42.00, it is both effective and accessible, making it a top choice for healthcare professionals and patients alike.
Health Benefits and Competitive Advantages
Choosing an antibiotic requires careful consideration of its benefits and potential advantages over other similar products. Rovamycine provides several key health benefits that make it a smart choice:
- Effective Antibacterial Action: The primary function of Spiramycin is to inhibit protein synthesis in bacteria, leading to their growth inhibition and eventual death. This unique mechanism makes it effective against a range of bacterial strains.
- Low Hepatotoxicity: Rovamycine has low levels of hepatotoxicity, making it safer for patients with liver concerns. This allows for broader use without significant risk of liver damage.
- No Significant Effects on Blood Pressure: Unlike other antibiotic options, Rovamycine does not significantly impact blood pressure, making it suitable for a wider demographic, including those with hypertension.
The Ideal Audience for Rovamycine 3.000.000 iu Eczacibasi
Rovamycine 3.000.000 iu Eczacibasi is tailored for individuals suffering from various bacterial infections that require effective treatment. Patients with conditions such as respiratory infections, certain skin infections, and other bacterial ailments may find this antibiotic particularly beneficial. Furthermore, it’s ideal for healthcare practitioners looking to prescribe a safe and effective treatment option for their patients. Additionally, it’s important for those considering this product to understand its recommended dosage—typically 2 to 3 million IU taken three times per day, allowing for effective management of their symptoms and promoting recovery.
Additional information
| Raw Material | Spiramisin |
|---|---|
| Water Retention | No significant effect |
| Hepatotoxicity | Low |
| Lab Test | Not typically required for monitoring |
| Also known as | Foromacidin |
| Blood pressure | No significant effects |
| Trade name | Rovamycin |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Chemical name | Spiramycin |
| Formula | C_43H_74N_2O_14 |
| Substance class | Macrolide antibiotic |
| Main action | Antibacterial |
| Half-life | Approximately 6 hours |
| Dosage (medical) | Typically 2 to 3 million IU, taken three times per day |
| Dosage (sports) | Not applicable |
| Effects | Inhibits protein synthesis in bacteria, leading to growth inhibition and death |
| Side effects | Diarrhea, nausea, vomiting, abdominal pain |
| Use in sports | None |
| Manufacturer | Eczacıbaşı |
| Packing | 1 x 14 tabs (3.000.000 ıu/tab) |





Reviews
There are no reviews yet.